-+ 0.00%
-+ 0.00%
-+ 0.00%

Spruce Biosciences FY 2025 R&D expenses fall 58% to USD 19.52 million, net loss narrows 27% to USD 38.97 million

Reuters·03/09/2026 11:05:25

Please log in to view news